Profile picture

Doctor Christopher Loughrey

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
Follow
Logo ESC

Contributor content

Targeting RUNX1 protects against diastolic dysfunction in a two-hit mouse model of heart failure with preserved ejection fraction
Journal
Targeting RUNX1 protects against diastolic dysfunction in a two-hit mouse model of heart failure with preserved ejection fraction
26 May 2026
See more
Ribonucleicacid interference or small molecule inhibition of <em>Runx</em>1 in the border zone prevents cardiac contractile dysfunction following myocardial infarction
Journal
Ribonucleicacid interference or small molecule inhibition of <em>Runx</em>1 in the border zone prevents cardiac contractile dysfunction following myocardial infarction
11 July 2023
See more
Inhibition of myocardial cathepsin-L release during reperfusion following myocardial infarction improves cardiac function and reduces infarct size
Journal
Inhibition of myocardial cathepsin-L release during reperfusion following myocardial infarction improves cardiac function and reduces infarct size
16 June 2021
See more
RUNX1: an emerging therapeutic target for cardiovascular disease
Journal
RUNX1: an emerging therapeutic target for cardiovascular disease
10 March 2020
See more
<em>Trypanosoma brucei</em> cathepsin-L increases arrhythmogenic sarcoplasmic reticulum-mediated calcium release in rat cardiomyocytes
Journal
<em>Trypanosoma brucei</em> cathepsin-L increases arrhythmogenic sarcoplasmic reticulum-mediated calcium release in rat cardiomyocytes
26 July 2013
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources